Senior Marketing global brand Manager
SPIMACO
Total des années d'expérience :15 years, 8 Mois
1. Build the strategic roadmap & implement the tactical activities platform that led to SPIMACO Neuroscience sector; Psychiatry arm, leadership in KSA market, by Launching & Managing both portfolios of:
• antipsychotics: Zolinda (Aripiprazole), Olenza (Olanzapine ODT), Quetta XR (Quetiapine XR), Resedra (Risperidone) and Palipra (Paliperidone) in KSA, UAE, Iraq and Sudan
• Hypnotics: Zolonia (Zolpidem) and Zonam (Eszopiclone) in KSA, UAE, Iraq and Sudan.
2. Designing, launching, and managing the leading direct-to-caregiver platform (I DO MIND) in Saudi Arabia to increase mental disorders awareness among Saudi population, aiming utmost patients’ clinical outcomes alongside maximum medication compliance towards a healthier Saudi population wellbeing.
1. Responsible for Neuroscience unit full-fledged marketing function duties & solutions for Antidepressants’ portfolio; Entapro (Escitalopram) and Venex XR (Venlafaxine) in alliance with Lundbeck in KSA, UAE and Lebanon
2. Responsible for strategic brand management and development of Diabetes unit brands’ equity.
• Launching & Managing DPP-4 inhibitors players; Glipten (Sitagliptin) and Gliptamet (Sitagliptin/Metformin) in alliance with MSD.
• Managing Sulfonylurea players; Glim (Glimepiride) and Glaze (Gliclazide) in KSA, UAE.
Leading two cross-functional; medical and Marketing, to deliver and participate in conduction of high-end marketing campaigns, launches and solutions for both multinational and regional pharmaceutical companies.
Performing all brand management responsible for both cardiovascular portfolio; X-Tension (Irbesartan), Normaten (Captopril) and Aggarex (Acetyl salicyclic acid) & Neuroscience portfolio; Lyrineur (Pregabalin).
Responsible for Neuroscience unit sales in Heliopolis area for Antiepileptics’ portfolio; Conventin (Gabapentin) and Pregavalex (pregabalin).
